Montelukast and Churg-Strauss syndrome [PDF]
Thorax, 2001 I read with interest the case report by Tuggey and Hosker where Churg-Strauss syndrome was associated with the use of montelukast in an asthmatic patient in whom there was no recent exposure to oral corticosteroid.1 However, it is worth noting that the patient was using a high dose of inhaled fluticasone propionate (1.5 mg/day) via a large volume ...
Brian J. Lipworth
+11 more sources
Calidad de prescripción de montelukast en pacientes adultos: Estudio en tres farmacias comunitarias de la Comunidad Valenciana [PDF]
Farmacéuticos Comunitarios, 2014 Introducción: El objetivo de este trabajo es analizar la utilización de montelukast en adultos desde tres farmacias comunitarias. Material y métodos: Estudio descriptivo, observacional en tres farmacias comunitarias (enero 2009 - febrero 2013) en ...
Peris Molina MT +3 more
doaj +2 more sources
Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial [PDF]
BMC GastroenterologyBackground Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ...
Kourosh Masnadi Shirazi +3 more
doaj +2 more sources
LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial. [PDF]
Clin Transl AllergyAbstract Background Anti‐IgE therapy can serve as an option for inadequately controlled seasonal allergic rhinitis (SAR) patients. LP‐003, a novel anti‐IgE antibody, is being tested as an add‐on treatment for SAR. This trial aimed to evaluate whether LP‐003 is effective and safe for SAR.
Guan K +12 more
europepmc +2 more sources
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report [PDF]
Frontiers in Clinical Diabetes and HealthcareIntroductionType 1 diabetes involves immune-mediated destruction of insulin-producing beta cells, with eosinophils potentially playing a significant role. Recent studies suggest that leukotriene inhibition might influence this process.
Pavel Fatulla +7 more
doaj +2 more sources
The Impact of Montelukast Duration on the Risk of Neuropsychiatric Disorders in Children with Asthma: A Population-Based Cohort Study [PDF]
PharmaceuticalsBackground/Objectives: Asthma is one of the most common chronic diseases in children, and montelukast is widely prescribed to manage symptoms. However, concerns have emerged regarding its potential association with neuropsychiatric disorders.
Wei-Te Lei +8 more
doaj +2 more sources
Sleeptalking! Sleepwalking! Side Effects of Montelukast
Case Reports in Pulmonology, 2013 A 16-year-old Caucasian female presented to the pulmonary clinic for a followup on her asthma. Due to the worsening of allergy-related symptoms, therapy with montelukast 10 mg daily was started and resulted in good relief of the patient’s symptoms.
Samer Alkhuja +2 more
doaj +4 more sources
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria [PDF]
, 2004 BACKGROUND: H 1 -receptor antagonists are considered to be particularly effective in reducing pruritus, and they are therefore recommended as first-line treatment in patients with chronic idiopathic urticaria (CIU).
DI LORENZO, G. +7 more
core +3 more sources
Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study [PDF]
Exploratory Research in Clinical and Social PharmacyObjective: To identify and evaluate montelukast deprescribing in outpatient specialty clinics. Methods: This was a single-center, retrospective, cross-sectional study conducted at an academic health system in the southern US including 21 specialty ...
David C. Foote +5 more
doaj +2 more sources